Market Intelligence Ecosystem
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Suneeta Reddy -- Managing Director Sanjiv Gupta -- CFO Unidentified Speaker --
Biocon Limited (NSE:BIOCON) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Saurabh Paliwal -- Head - Investor Relations Kiran Mazumdar Shaw -- Biocon Ltd.
Key highlights from Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Q&A Highlights: [00:08:54] Riddhesh Gandhi from Discovery Capital asked why there
Neuland Laboratories Limited (NSE:NEULANDLAB) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Abhijit Majumdar -- Chief Financial Officer Saharsh Davuluri -- Vice Chairman and
Krsnaa Diagnostics Ltd (NSE:KRSNAA) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Pallavi Bhatevara -- Managing Director Pawan Daga -- Chief Financial Officer Yash
Marksans Pharma Limited (NSE:MARKSANS) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Mark Saldanha -- Managing Director and Chief Executive Officer Jitendra
Biocon Limited (NSE:BIOCON) is an Indian multinational biopharmaceutical company based in Bangalore, India. The company was founded in 1978 by Kiran Mazumdar-Shaw
Brooks Laboratories Limited (NSE: BROOKS) is a pharmaceutical contract research and manufacturing services company based in India. It offers a range of
Themis Medicare Ltd (NSE:THEMISMED) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Sachin D. Patel -- Managing Director and Chief Executive Officer
Rainbow Children's Medicare Ltd (NSE:RAINBOW) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Ramesh Kancharla -- Chairman and Managing Director R. Gowrisankar -- Chief
Panacea Biotec Limited’s revenue in Q3FY23 fell 26% to ₹ 11,520 lakhs. Consolidated Profit After Tax came at ₹ 1,937 lakhs in
Fortis Healthcare Ltd (NSE:FORTIS) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Anurag Kalra -- Senior Vice President, Investor Relations Ashutosh Raghuvanshi -- Managing
Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Utkarsh Gandhi -- General Manager, Investor Relations Glenn Saldanha -- Chairman and
Metropolis Healthcare Limited (NSE:METROPOLIS) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Cyndrella Carvalho -- Vice President - Healthcare/Pharma Lead at JM
Alembic Pharmaceuticals Ltd. (NSE:APLLTD) is an Indian pharmaceutical company that was founded in 1907. It is headquartered in Vadodara, Gujarat, and operates
Key highlights from Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Management Update: [00:03:30] LUPIN said it is optimistic of growing its US
Ajanta Pharma Limited (NSE: AJANTAPHARMA) is an Indian pharmaceutical company that specializes in the production and distribution of generic drugs. The company
Strides Pharma Science Limited (NSE:STAR) Q3 FY23 Earnings Concall dated Jan. 24, 2023. Corporate Participants: Abhishek Singhal -- Investor Relations Arun Kumar -- Executive Chairperson &
Alkem Laboratories Ltd (NSE:ALKEM) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Tushar Manudhane -- Investor Relations Amit Kumar Khandelia -- AVP Finance Sandeep
Lupin Ltd (NSE:LUPIN) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director, Global Chief